TAT and brain ischemia: The lack of TFPI K1 domain also leads to elevated thrombin-antithrombin (TAT) levels, aberrant renal fibrin deposition, extensive brain ischemia and infarction, and an increased risk of the TF-induced pulmonary thromboembolism [43].